1. 376PDImpact of a molecular prescreening program (MPP) in the management of patients with non-glioblastoma brain tumors. (23rd October 2018) Authors: Benítez Montañez, J C; Vieito Villar, M; Hierro, C; Gonzalez Rodriguez, M; Matos, I; Braña Garcia, I; Suarez Rodriguez, C; Martinez Saez, E A; Perez-Gago, M C; Morales-Barrera, R; Ortiz, C; Suarez, C; Maldonado, X; Martinez-Ricarte, F; Auger, C; Azaro, A; Dienstmann, R; Carles, J; Garralda, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SGLT1/2 expression in the heart of transplanted patients is associated with inflammatory induction of oxidative stress: potential protective effect of SGLT2 inhibitors. (3rd October 2022) Authors: Gong, D S; Mroueh, A; Matsushita, K; Fakih, W; Auger, C; Oak, M H; Pieper, M P; Morel, O; Epailly, E; Schini-Kerth, V Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Upregulation of SGLT1 and 2 promotes oxidative stress in right atrial appendages of patients with low-grade inflammatory responses: potential role in atrial fibrillation. (3rd October 2022) Authors: Fakih, W; Mroueh, A; Auger, C; Kindo, M P; Mommerot, A; Mazzucotelli, J P; Pieper, M P; Ohlmann, P; Morel, O; Schini-Kerth, V; Jesel, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Significant clinical worsening after natalizumab withdrawal: Predictive factors. (May 2015) Authors: Vidal-Jordana, A; Tintoré, M; Tur, C; Pérez-Miralles, F; Auger, C; Río, J; Nos, C; Arrambide, G; Comabella, M; Galán, I; Castilló, J; Sastre-Garriga, J; Rovira, A; Montalban, X Journal: Multiple sclerosis Issue: Volume 21:Number 6(2015) Page Start: 780 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Brain atrophy in natalizumab-treated patients: A 3-year follow-up. (May 2015) Authors: Sastre-Garriga, J; Tur, C; Pareto, D; Vidal-Jordana, A; Auger, C; Río, J; Huerga, E; Tintoré, M; Rovira, A; Montalban, X Journal: Multiple sclerosis Issue: Volume 21:Number 6(2015) Page Start: 749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation. Issue 9 (September 2018) Authors: Principe, M; Chanal, M; Karam, V; Wierinckx, A; Mikaélian, I; Gadet, R; Auger, C; Raverot, V; Jouanneau, E; Vasiljevic, A; Hennino, A; Raverot, G; Bertolino, P Journal: Endocrine-related cancer Issue: Volume 25:Issue 9(2018) Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction. (25th November 2020) Authors: Bruckert, C; Remila, L; Matsushita, K; Auger, C; Houngue, U; Chaker, A; Park, S; Algara-Suarez, P; Belcastro, E; Jesel, L; Ohlmann, P; Morel, O; Schini-Kerth, V Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury – potential role of angiotensin and purinergic signaling. (14th October 2021) Authors: Matsushita, K; Sato, C; Bruckert, C; Gong, D; Hmadeh, S; Fakih, W; Remila, L; Auger, C; Jesel, L; Ohlmann, P; Kauffenstein, G; Schini-Kerth, V; Morel, O Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗